121 related articles for article (PubMed ID: 35394495)
21. Leukemic evolution of donor-derived cells harboring IDH2 and DNMT3A mutations after allogeneic stem cell transplantation.
Yasuda T; Ueno T; Fukumura K; Yamato A; Ando M; Yamaguchi H; Soda M; Kawazu M; Sai E; Yamashita Y; Murata M; Kiyoi H; Naoe T; Mano H
Leukemia; 2014 Feb; 28(2):426-8. PubMed ID: 24067491
[No Abstract] [Full Text] [Related]
22. DNMT3A haploinsufficiency causes dichotomous DNA methylation defects at enhancers in mature human immune cells.
Lim JY; Duttke SH; Baker TS; Lee J; Gambino KJ; Venturini NJ; Ho JSY; Zheng S; Fstkchyan YS; Pillai V; Fajgenbaum DC; Marazzi I; Benner C; Byun M
J Exp Med; 2021 Jul; 218(7):. PubMed ID: 33970190
[TBL] [Abstract][Full Text] [Related]
23. DNMT3A DNA-Binding Residues Provide Specificity for CpG DNA Methylation.
Cancer Discov; 2018 Apr; 8(4):OF14. PubMed ID: 29453236
[TBL] [Abstract][Full Text] [Related]
24. Dnmt3a-null hematopoietic stem and progenitor cells expand after busulfan treatment.
Chen J; Matatall KA; Feng X; Hormaechea-Agulla D; Maharjan M; Young N; King KY
Exp Hematol; 2020 Nov; 91():39-45.e2. PubMed ID: 32961298
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory signals from fatty bone marrow support DNMT3A driven clonal hematopoiesis.
Zioni N; Bercovich AA; Chapal-Ilani N; Bacharach T; Rappoport N; Solomon A; Avraham R; Kopitman E; Porat Z; Sacma M; Hartmut G; Scheller M; Muller-Tidow C; Lipka D; Shlush E; Minden M; Kaushansky N; Shlush LI
Nat Commun; 2023 Apr; 14(1):2070. PubMed ID: 37045808
[TBL] [Abstract][Full Text] [Related]
26. Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome.
Tovy A; Rosas C; Gaikwad AS; Medrano G; Zhang L; Reyes JM; Huang YH; Arakawa T; Kurtz K; Conneely SE; Guzman AG; Aguilar R; Gao A; Chen CW; Kim JJ; Carter MT; Lasa-Aranzasti A; Valenzuela I; Van Maldergem L; Brunetti L; Hicks MJ; Marcogliese AN; Goodell MA; Rau RE
Haematologica; 2022 Apr; 107(4):887-898. PubMed ID: 34092059
[TBL] [Abstract][Full Text] [Related]
27. The methyltransferase domain of DNMT1 is an essential domain in acute myeloid leukemia independent of DNMT3A mutation.
Bhogal B; Weir BA; Crescenzo R; Marien A; Kwon MC; Philippar U; Cowley GS
Commun Biol; 2022 Nov; 5(1):1174. PubMed ID: 36329185
[TBL] [Abstract][Full Text] [Related]
28. Dnmt3a silences hematopoietic stem cell self-renewal.
Trowbridge JJ; Orkin SH
Nat Genet; 2011 Dec; 44(1):13-4. PubMed ID: 22200773
[TBL] [Abstract][Full Text] [Related]
29. Clonal hematopoiesis by DNMT3A mutations as a common finding in idiopathic splanchnic vein thrombosis.
Carrà G; Giugliano E; Camerlo S; Rosati G; Branca E; Maffeo B; Russo I; Piazza R; Cilloni D; Morotti A
Haematologica; 2023 May; 108(5):1447-1449. PubMed ID: 36226499
[No Abstract] [Full Text] [Related]
30. Alterations to
Venugopal K; Feng Y; Shabashvili D; Guryanova OA
Cancer Res; 2021 Jan; 81(2):254-263. PubMed ID: 33087320
[TBL] [Abstract][Full Text] [Related]
31. FLT3-ITD with DNMT3A R882 double mutation is a poor prognostic factor in Chinese patients with acute myeloid leukemia after chemotherapy or allogeneic hematopoietic stem cell transplantation.
Tang S; Shen H; Mao X; Dai H; Zhu X; Xue S; Ding Z; Lu J; Wu D; Tang X
Int J Hematol; 2017 Oct; 106(4):552-561. PubMed ID: 28616699
[TBL] [Abstract][Full Text] [Related]
32. DNMT3A Loss Drives Enhancer Hypomethylation in FLT3-ITD-Associated Leukemias.
Yang L; Rodriguez B; Mayle A; Park HJ; Lin X; Luo M; Jeong M; Curry CV; Kim SB; Ruau D; Zhang X; Zhou T; Zhou M; Rebel VI; Challen GA; Gottgens B; Lee JS; Rau R; Li W; Goodell MA
Cancer Cell; 2016 Jun; 29(6):922-934. PubMed ID: 27300438
[TBL] [Abstract][Full Text] [Related]
33. Domain Structure of the Dnmt1, Dnmt3a, and Dnmt3b DNA Methyltransferases.
Tajima S; Suetake I; Takeshita K; Nakagawa A; Kimura H; Song J
Adv Exp Med Biol; 2022; 1389():45-68. PubMed ID: 36350506
[TBL] [Abstract][Full Text] [Related]
34. KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogramming.
Na F; Pan X; Chen J; Chen X; Wang M; Chi P; You L; Zhang L; Zhong A; Zhao L; Dai S; Zhang M; Wang Y; Wang B; Zheng J; Wang Y; Xu J; Wang J; Wu B; Chen M; Liu H; Xue J; Huang M; Gong Y; Zhu J; Zhou L; Zhang Y; Yu M; Tian P; Fan M; Lu Z; Xue Z; Zhao Y; Yang H; Zhao C; Wang Y; Han J; Yang S; Xie D; Chen L; Zhong Q; Zeng M; Lowe SW; Lu Y; Liu Y; Wei Y; Chen C
Nat Cancer; 2022 Jun; 3(6):753-767. PubMed ID: 35449309
[TBL] [Abstract][Full Text] [Related]
35. Infection makes micro-CHIPs into macro-CHIPs.
Gopakumar J; Jaiswal S
Cell Stem Cell; 2021 Aug; 28(8):1335-1336. PubMed ID: 34358435
[TBL] [Abstract][Full Text] [Related]
36. Cell origin-dependent cooperativity of mutant Dnmt3a and Npm1 in clonal hematopoiesis and myeloid malignancy.
SanMiguel JM; Eudy E; Loberg MA; Miles LA; Stearns T; Mistry JJ; Rauh MJ; Levine RL; Trowbridge JJ
Blood Adv; 2022 Jun; 6(12):3666-3677. PubMed ID: 35413095
[TBL] [Abstract][Full Text] [Related]
37. RNAi-Mediated Screen of Primary AML Cells Nominates MDM4 as a Therapeutic Target in NK-AML with
Sidorova OA; Sayed S; Paszkowski-Rogacz M; Seifert M; Camgöz A; Roeder I; Bornhäuser M; Thiede C; Buchholz F
Cells; 2022 Mar; 11(5):. PubMed ID: 35269477
[No Abstract] [Full Text] [Related]
38. DNMT3A R882H mutation promotes acute leukemic cell survival by regulating glycolysis through the NRF2/NQO1 axis.
Chu X; Zhong L; Dan W; Wang X; Zhang Z; Liu Z; Lu Y; Shao X; Zhou Z; Chen S; Liu B
Cell Signal; 2023 May; 105():110626. PubMed ID: 36758683
[TBL] [Abstract][Full Text] [Related]
39. Impact of G-Quadruplex Structures on Methylation of Model Substrates by DNA Methyltransferase Dnmt3a.
Loiko AG; Sergeev AV; Genatullina AI; Monakhova MV; Kubareva EA; Dolinnaya NG; Gromova ES
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142137
[TBL] [Abstract][Full Text] [Related]
40. Single substitution in H3.3G34 alters DNMT3A recruitment to cause progressive neurodegeneration.
Khazaei S; Chen CCL; Andrade AF; Kabir N; Azarafshar P; Morcos SM; França JA; Lopes M; Lund PJ; Danieau G; Worme S; Adnani L; Nzirorera N; Chen X; Yogarajah G; Russo C; Zeinieh M; Wong CJ; Bryant L; Hébert S; Tong B; Sihota TS; Faury D; Puligandla E; Jawhar W; Sandy V; Cowan M; Nakada EM; Jerome-Majewska LA; Ellezam B; Gomes CC; Denecke J; Lessel D; McDonald MT; Pizoli CE; Taylor K; Cocanougher BT; Bhoj EJ; Gingras AC; Garcia BA; Lu C; Campos EI; Kleinman CL; Garzia L; Jabado N
Cell; 2023 Mar; 186(6):1162-1178.e20. PubMed ID: 36931244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
